Amass Connector listing history

The biomedical intelligence layer for AI

Search and reason across 60M+ cross-linked life science records — including peer-reviewed publications, conferences, clinical trials, drugs, genes, regulatory approvals, and patents — from a single connector.

Instead of searching individual databases, Amass gives Claude access to a unified biomedical knowledge layer where entities are linked across sources, enabling richer retrieval, evidence synthesis, and scientific reasoning with full source attribution.

What you can do

Use Amass to power workflows such as:

• Scientific literature reviews
• Drug and target discovery
• Clinical trial landscape analysis
• Regulatory intelligence (FDA & EMA)
• Drug approval and label comparison
• Patent landscape and freedom-to-operate research
• Gene, target and biomarker exploration
• Due diligence and competitive intelligence
• AI agents that require grounded biomedical evidence

Included *Cores

BioMedCore BioMedCore (43M+ records: peer-reviewed publications from PubMed/PMC and conference abstracts from society meetings)

TrialCore 1.2M+ clinical trials from ClinicalTrials.gov and international registries (ChiCTR, CTRI, EU-CTR, JPRN, IRCT, and more), linked to drugs, diseases, publications and regulatory outcomes.

DrugCore 22K+ harmonized drugs and molecules — including 5,200+ approved — with modality, mechanism of action, targets, development stage, synonyms, structures and ChEMBL relationships.

RegulatoryCore 7K+ FDA and EMA approvals, backed by 466K+ parsed document sections — labels, SmPCs, EPARs, review documents and regulatory history.

GeneCore 42K+ human genes enriched with target intelligence, druggability, clinical evidence, tractability, DepMap essentiality, safety liabilities and cross-links to drugs, trials and publications.

PatentCore (Preview) 16M+ life science patents with full-text search, CPC/IPC classifications, patent families, assignees, inventors and chemical compounds.